Put simply, we know these drugs work ... actions that may contribute to its antidepressant effect, but no clear specific mechanism of action. It appears to be a mild monoamine oxidase inhibitor ...
Lycopene, a natural plant extract, reduced depression-related impairments in the hippocampus and alleviated depressive-like ...
we believe that DOP agonists have an unprecedented mechanism of action and have the potential to revolutionize depression treatment with superior efficacy and safety compared to existing drugs." ...
Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary name ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
Researchers at the University of Basel are able to test in parallel the effects of over 1,500 active substances on cell ...
The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...
Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel mechanisms of action.
Research into ENA-001 is also supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under award number R44DA057133. The content of this document is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback